Hangzhou Tigermed Consulting Co Ltd Sustainability Reports
The company operates as a clinical Contract Research Organization (CRO) that provides comprehensive research and development services for the biopharmaceutical and medical device industries. Its offerings span across preclinical development, clinical trials, and clinical research consulting services.
Sector: Professional & technical services
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG002PKXG10
12 reports from 2018 to 2025
- Hangzhou Tigermed Consulting Co Ltd 2025 Sustainability Report
- Hangzhou Tigermed Consulting Co Ltd 2024 Annual Report
- Hangzhou Tigermed Consulting Co Ltd 2023 Annual Report
- Hangzhou Tigermed Consulting Co Ltd 2023 Sustainability Report and Environmental, Social and Governance (ESG) Report
- Hangzhou Tigermed Consulting Co Ltd 2022 Annual Report